News

Alpha Metallurgical Resources Reveals Q4 2024 Financial Performance

Alpha Metallurgical Resources Reveals Q4 2024 Financial Performance

Alpha Metallurgical Resources Reports Fourth Quarter 2024 Results

Alpha Metallurgical Resources, Inc. (NYSE: AMR), a prominent supplier in the metallurgical coal industry, has shared its financial results for the fourth quarter of 2024. Despite facing challenges in the market, the company remains focused on executing its strategic plans and navigating through this landscape effectively.

Key Financial Highlights

For the fourth quarter of 2024, Alpha reported a net loss of $2.1 million, reflecting a loss of $0.16 per diluted share. This marks a significant change from the previous quarter, where the company achieved a net income of $3.8 million. The results underscore the continued pressure on coal pricing and demand.

Adjusted EBITDA Results

In this quarter, the company posted an Adjusted EBITDA of $53.2 million, up from $49.0 million in the third quarter of 2024. This indicates a strong operational performance despite the overall net loss.

Operational Updates

Looking forward to 2025, Alpha is modifying its volume guidance for metallurgical coal shipments, reducing it to a range of 14.5 million to 15.5 million tons, down from the previous outlook. The adjustments respond to a diminished demand forecast and operational disruptions due to adverse weather conditions in the early months of the year. Additionally, the cost of coal sales guidance for 2025 has been revised upward, now forecasting a range between $103.00 and $110.00 per ton.

Liquidity and Financial Position

Cash provided by operating activities has decreased considerably in the fourth quarter, amounting to $56.3 million compared to $189.5 million in the third quarter of 2024. The latter benefited from a decrease in working capital, which contributed to higher cash inflow. As of the end of the quarter, the company reported total liquidity of $519.4 million, bolstered by cash and cash equivalents, and unused availability under its asset-based revolving credit facility.

Share Repurchase Program

Alpha's board has authorized a share repurchase program, permitting the expenditure of up to $1.5 billion in repurchasing common stock. As of February 21, 2025, approximately 6.6 million shares have been repurchased at an average cost of $165.74 per share. This move reflects the board's confidence in the company's long-term value and commitment to returning capital to shareholders.

Market Adaptations and Future Guidance

Alpha continues to adapt to the changing market conditions impacting the metallurgical coal sector. The anticipated decrease in shipment volumes and rising costs for coal sales signify the company’s focus on strategic realignment with market realities. The management remains committed to optimizing operational efficiencies and navigating the challenges presented by market shifts.

Investors' Insights

Investors should remain aware of the underlying trends affecting Alpha’s operation and financial outlook as the company aims to stabilize its performance while addressing significant market challenges. The adjusted shipment guidance and increased cost projections are critical indicators of the company’s financial strategy moving forward.

Conclusion

In summary, Alpha Metallurgical Resources is diligently navigating a complex market environment, aiming to sustain operational stability while ensuring financial robustness. Stakeholders are encouraged to monitor further updates as the company executes its plans for 2025 and beyond.

Frequently Asked Questions

1. What were Alpha Metallurgical Resources' fourth quarter losses compared to previous quarters?

Alpha reported a net loss of $2.1 million for Q4 2024, down from a net income of $3.8 million in Q3 2024.

2. What is Alpha's current adjusted EBITDA for Q4 2024?

The adjusted EBITDA for Alpha in the fourth quarter of 2024 was $53.2 million, a slight increase from $49.0 million in the prior quarter.

3. How has the company adjusted its 2025 guidance?

Alpha has reduced its metallurgical coal shipment guidance for 2025 to between 14.5 million and 15.5 million tons, increased its cost guidance to a range of $103.00 to $110.00 per ton.

4. What is the company's position on its liquidity?

As of the end of Q4 2024, Alpha reported total liquidity of $519.4 million, strengthened by cash reserves and undrawn credit facilities.

5. What is the share repurchase program announced by Alpha?

Alpha's board has approved a share repurchase program to spend up to $1.5 billion for buying back its common stock, with 6.6 million shares already repurchased at an average cost of $165.74.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 158

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 119

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 183

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 211

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 139

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading